arrow
I

Inge Søkilde Pedersen

Department of Molecular Diagnostics
H指数:38
被引数:5,805

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Constitutional methylation of the MLH1 promoter: a case series including tumors not typically caused by Lynch Syndrome

MLH1启动子的构成性甲基化:包括非典型林奇综合征相关肿瘤的病例系列研究

2026-06-030
OAAI
Genome-wide association study of 398,238 women unveils seven loci associated with high-grade serous ovarian cancer

398,238名女性的全基因组关联研究揭示了七个与高级别浆液性卵巢癌相关的位点

2025-11-200
OAAI
Mild pancreatic fibrosis with preserved exocrine function and increased visceral adipose tissue in m.3243 A > G carriers: A magnetic resonance imaging study

轻度胰腺纤维化伴外分泌功能保存及内脏脂肪组织增加:m.3243 A > G携带者的磁共振成像研究

2025-11-020
OAAI
Timely germline BRCA testing after invasive breast cancer promotes contralateral risk-reducing mastectomy and improves survival: an observational retrospective study

乳腺癌术后及时进行胚系BRCA检测可促进对侧风险降低性乳房切除术并改善生存率:一项观察性回顾性研究

2025-05-230
OA
Longer survival with precision medicine in late-stage cancer patients

晚期癌症患者使用精准医学的生存期更长

2025-01-010
OAAI
Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel
2024-09-0112
OAAI
Promoter hypermethylation of SFRP1 as a prognostic and potentially predictive blood-based biomarker in patients with localized pancreatic ductal adenocarcinoma

SFRP1的启动子高甲基化作为局限性胰腺导管腺癌患者的预后和潜在预测血液生物标志物

2023-06-023
OAAI
Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2

卵巢癌病理特征是BRCA1和BRCA2变异致病性的预测因子

2023-04-198
OA